EUVIMEDEUVIMED entdecken
Crossref

Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties

Huaxin Song iD, Jiale Wu, Yigang Tang iD, Yuting Dai iD, Xinrong Xiang, Ya Li, Lili Wu, Jiaqi Wu, Ying Liang, Yangfei Xing, Ni Yan iD, Yuntong Li iD und 13 weitere

Science Translational Medicine · 05.04.2023 · 15 (690)

DOI: 10.1126/scitranslmed.abn9155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 05.04.2023. Verfasst von Huaxin Song und 24 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin H…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Neoplasms. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor suppressor p53 is inactivated by thousands of heterogeneous mutations in cancer, but their individual druggability remains largely elusive. Here, we evaluated 800 common p53 mutants for their rescue potencies by the representative generic rescue compound arsenic trioxide (ATO) in terms of transactivation activity, cell growth inhibition, and mouse tumor–suppressive activities. The rescue potencies were mainly determined by the solvent accessibility of the mutated residue, a key factor determining whether a mutation is a structural one, and the temperature sensitivity, the ability to reassemble the wild-type DNA binding surface at a low temperature, of the mutant protein. A total of 390 p53 mutants were rescued to varying degrees and thus were termed as type 1, type 2a, and type 2b mutations, depending on the degree to which they were rescued. The 33 type 1 mutations were rescued to amounts comparable to the wild type. In PDX mouse trials, ATO preferentially inhibited growth of tumors harboring type 1 and type 2a mutants. In an ATO clinical trial, we report the first-in-human mutant p53 reactivation in a patient harboring the type 1 V272M mutant. In 47 cell lines derived from 10 cancer types, ATO preferentially and effectively rescued type 1 and type 2a mutants, supporting the broad applicability of ATO in rescuing mutant p53. Our study provides the scientific and clinical communities with a resource of the druggabilities of numerous p53 mutations ( www.rescuep53.net ) and proposes a conceptual p53-targeting strategy based on individual mutant alleles rather than mutation type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53NeoplasmsHumansAnimalsMiceArsenic TrioxideApoptosisMutation

Substanzen

Arsenic TrioxideTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 20…
  • Hematology Research Laboratory, West China Hospital, Department of Hematology, Sichuan University, Chengdu, Sichuan 610041, China.
  • Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.

ORCID-Profile: Huaxin Song, Yigang Tang, Yuting Dai, Ni Yan, Yuntong Li, Hai Fang, Yuting Ma, Min Lu

Zitieren

APA

Song, H., Wu, J., Tang, Y., Dai, Y., Xiang, X., Li, Y., Wu, L., Wu, J., Liang, Y., Xing, Y., Yan, N., Li, Y., Wang, Z., Xiao, S., Li, J., Zheng, D., Chen, X., Fang, H., Ye, C., …, & Lu, M. (2023). Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties. Science Translational Medicine, 15(690). https://doi.org/10.1126/scitranslmed.abn9155

Vancouver

Song H, Wu J, Tang Y, Dai Y, Xiang X, Li Y, et al. Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties. Science Translational Medicine. 2023;15(690). doi:10.1126/scitranslmed.abn9155

BibTeX
@article{Song2023,
  author = {Song, Huaxin and Wu, Jiale and Tang, Yigang and Dai, Yuting and Xiang, Xinrong and Li, Ya and Wu, Lili and Wu, Jiaqi and Liang, Ying and Xing, Yangfei and Yan, Ni and Li, Yuntong and Wang, Zhengyuan and Xiao, Shujun and Li, Jiabing and Zheng, Derun and Chen, Xinjie and Fang, Hai and Ye, Chenjing and Ma, Yuting and Wu, Yu and Wu, Wen and Li, Junming and Zhang, Sujiang and Lu, Min},
  title = {Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties},
  journal = {Science Translational Medicine},
  year = {2023},
  volume = {15},
  number = {690},
  doi = {10.1126/scitranslmed.abn9155}
}
Kostenlos starten →